Adults with X-linked agammaglobulinemia: impact of disease on daily lives, quality of life, educational and socioeconomic status, knowledge of inheritance, and reproductive attitudes.

Medicine (Baltimore)

From Department of Pediatrics (JAW, CJ), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Immunology (MEC, VH), St. Jude Children's Research Hospital, Memphis, TN; and Abt SRBI Inc (JB), Silver Spring, MD.

Published: September 2008

Since many children with X-linked agammaglobulinemia (XLA) can now be expected to reach adulthood, knowledge of the status of adults with XLA would be of importance to the patients, their families, and the physicians caring for these patients. We performed the current study in adults with XLA to examine the impact of XLA on their daily lives and quality of life, their educational and socioeconomic status, their knowledge of the inheritance of their disorder, and their reproductive attitudes. Physicians who had entered adult patients with XLA in a national registry were asked to pass on a survey instrument to their patients. The patients then filled out the survey instrument and returned it directly to the investigators. Adults with XLA were hospitalized more frequently and missed more work and/or school than did the general United States population. However, their quality of life was comparable to that of the general United States population. They achieved a higher level of education and had a higher income than did the general United States population. Their knowledge of the inheritance of their disease was excellent. Sixty percent of them would not exercise any reproductive planning options as a result of their disease. The results of the current study suggest that although the disease impacts the daily lives of adults with XLA, they still become productive members of society and excel in many areas.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831411PMC
http://dx.doi.org/10.1097/MD.0b013e318187ed81DOI Listing

Publication Analysis

Top Keywords

adults xla
16
daily lives
12
quality life
12
knowledge inheritance
12
general united
12
united states
12
states population
12
x-linked agammaglobulinemia
8
lives quality
8
life educational
8

Similar Publications

Outcomes of X-Linked Agammaglobulinaemia Patients.

J Clin Immunol

November 2024

Newcastle upon Tyne NHS Foundation Trust, Newcastle upon Tyne, UK.

Background: X-linked agammaglobulinaemia (XLA), caused by mutations in BTK, is characterised by low or absent peripheral CD19 + B lymphocytes and agammaglobulinaemia. The mainstay of treatment consists of immunoglobulin replacement therapy (IgRT). As this cannot fully compensate for the immune defects in XLA, patients may therefore continue to be at risk of complications.

View Article and Find Full Text PDF

Mycoplasma pneumonia in a patient with X-linked agammaglobulinemia.

BMC Infect Dis

September 2024

Department of Infectious Diseases, Henan Children's Hospital, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou Children's Hospital, Zhengzhou, 450018, China.

Article Synopsis
  • X-linked agammaglobulinemia (XLA) is a rare genetic disorder that impacts the immune system, also known as Bruton's tyrosine kinase deficiency.
  • Researchers used Next-Generation Sequencing to analyze the genetics of patients with immunodeficiency and their relatives.
  • The goal was to provide accurate diagnoses, genetic counseling, and improve understanding of XLA.
View Article and Find Full Text PDF
Article Synopsis
  • The study explores how different BTK mutations in X-linked agammaglobulinemia (XLA) impact TLR signaling pathways, potentially affecting the severity of the disease.
  • Researchers quantified gene expression related to TLR pathways in XLA patients with different BTK mutations compared to healthy controls, finding varying levels of regulation among key genes.
  • The results suggest that abnormal expression levels of certain TLR genes could make XLA patients more prone to infections or contribute to chronic inflammatory diseases, highlighting the inflammatory aspect present even with treatment.
View Article and Find Full Text PDF

Discordant Phenotypes of Nephritis in Patients with X-linked Agammaglobulinemia.

J Clin Immunol

July 2024

Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), 1-3-45 Yushima, Bunkyo-ku, 113-8519, Tokyo, Japan.

Purpose: To define the clinical and histological characteristics of nephritis in patients with X-linked agammaglobulinemia (XLA) and their immunological profiles.

Methods: The clinical, immunological, and histological findings of nine patients with XLA and nephritis were retrospectively analyzed.

Results: Based on kidney histological findings, patients with XLA and nephritis could be divided into two groups, viz.

View Article and Find Full Text PDF

Purpose: Previous studies have demonstrated that the majority of patients with an inborn error of immunity (IEI) develop a spike (S)-specific IgG antibody and T-cell response after two doses of the mRNA-1273 COVID-19 vaccine, but little is known about the response to a booster vaccination. We studied the immune responses 8 weeks after booster vaccination with mRNA-based COVID-19 vaccines in 171 IEI patients. Moreover, we evaluated the clinical outcomes in these patients one year after the start of the Dutch COVID-19 vaccination campaign.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!